Reneuron Share Discussion Threads

[king1pin2] 03/10/2019 17:14

lol the trend was just short of £3.00 after the rns .

[costax1654x] 03/10/2019 16:43

Below 100 if it keeps the trend

[dickbush] 03/10/2019 16:39

Thanks, wigwammer for the information on Eylea and Lucentis. Very encouraging.

[wigwammer] 03/10/2019 16:08

S1ze has a point. If you're here long term it doesn't matter. I'm happy to stick it out, but then it's been one of my better calls... @310p..."30/4/2019 16:35 wigwammer: Tend to agree with rayrac - I have taken out my original investment at £3+ and happy to let the rest run. If we do have a game changing asset I will still be a very happy man :)"

[eggy6198] 03/10/2019 15:59

dont fancy eyla

[king1pin2] 03/10/2019 15:59

I dont think anyone can say where the price of this will be over the next few days and in the run up to the conferance . Have been around stockmarkets since 86 and watched my fair share of bad and good news unfold on BBs just like this what i can say is that this share will recover a fair amount of ground at some point.
I was very surprised to see the shares down by this amount today so expect to see this bounce later today or friday.
Very very bad news is down , down , down , everyday but this is not like that so we will get a bounce .

[wigwammer] 03/10/2019 15:53

Similar story with Eylea. Sales circa $4bn pa. Injection into eye once every other month. Side effects.. "burst blood vessel in the eye, eye pain or discomfort after the injection, cataracts, watery eyes, blurred vision,swelling of the eyelids, vitreous detachment, eye "floaters,"increased pressure within the eye,andfeeling as if something is in the eye."

[wigwammer] 03/10/2019 15:49

Lucentis sale $1.7bn. Eye injection once a month. It carries this warning "Side effects have been seen with LUCENTIS, including serious eye infections and detached retinas."... ie surgical related issues and more frequent eye injections are not necessarily obstacles to building a valuable treatment if the efficacy is there :)

[eggy6198] 03/10/2019 15:42

facts all in your favour right now bar the products works and people are worried about that which is why we are here. you be gone after conference and this is explained and market understands.

so fair play this drop is unjustified but will stop at some point

[wigwammer] 03/10/2019 15:35

Eylea injected into eye once every 8 weeks. Lucentis injected into eye once every 4 weeks. Efficacy in low baseline patients here lasts 6 months+ from one injection. All these things people don't have knowledge about - but they sell anyway :)

[s1zematters] 03/10/2019 15:24

Dearest Peggy,
Please do not concern yourself with the rush and push of the daily share price, for if you really were a genuine investor such falls wouldn't concern you; as no doubt the treatment will eventually come good and the share price will 10 bag?

The only people that should be worried are the red/black aim gamblers skip rats caught trying to make an uneducated punt and a quick buck, and now hold the classic busted flush .
They are the ones who seem to cry about the price action on such falls, hey Peggy?

-----------------------------------------------------------------------------------
EGGY6198 - 03 Oct 2019 - 13:04:30 - 7262 of 7274 business - RENE

If woodford isnt selling this is just fixed. How low can they take it is the only question before the conference

---------------------------------------------------------------------------------
EGGY6198 - 02 Oct 2019 - 15:49:22 - 7196 of 7274 RENE
Clearly this has been shorted at this point cant all want in below 2 quid. Its hard to understand this drop other than BS and shorters

--------------------------------------------------------------------------------
EGGY6198 - 02 Oct 2019 - 15:38:58 - 7194 of 7275 RENE
I really wish derampers would f off why would it go 120? The mcap is alreadynpeanuts and the product works.

[eggy6198] 03/10/2019 15:16

strange lad are you not at least say you have a short?

[s1zematters] 03/10/2019 15:00

Yes we can all pretend to know Dave; It's just evidently some of us seem greater informed than others in their formulation of predictions don't you think?
Some put "190p very short term" price prediction up for scrutiny on this very board when the price was 260p yesterday and other didn't?

Indeed some one here was even predicting shorters would be on "toast" yesterday morning, were they not Dave (cough)

So we have two polar extremes my dear friend; you being hopelessly wrong on one end and then me, well vanity stops me completing this sentence ;)

My 120p-140p target i talked about yesterday that sent you and dearest Peggy over the top, not only remains in place but now looks modest !





InvestorDave - 02 Oct 2019 - 07:34:37 - 7112 of 7272 ReNeuron - a leading, clinical-stage stem cell business - RENE
Shorters on toast. A lovely sight.

[investordave] 03/10/2019 14:51

Sorry to see you've bailed. As I recall you've been a RENE holder for sometime.

[investordave] 03/10/2019 14:48

We can all pretend to know where the share price will fall in circumstances like this. In reality nobody knows including our esteemed friend the sized one.

[investordave] 03/10/2019 14:47

He doesn't have one. Another Walter Mitty character I fear with illusions of grandeur. Best ignored.

[rrb] 03/10/2019 13:55

I have said before, this is the wrong move. The results were never likely to be blowout. If they were, this stock would be at £10. What you want to see is progress and potential. There are so many nuances in the data released yesterday. The 2 visual loss patients bring down the average. The higher baseline vision brings down the average. The conclusion is this looks like it works for patients whose disease is more advanced. Now given these patients are essentially blind anyway, there is only upside for them to go for the treatment.

In terms of cash - they have c£26m. I expect they will hit milestones for further cash from Fosun. And this is assuming no deals in Europe and US. Meanwhile, we have conference presentations to look forward to and shares will recover into that. So all in all, this is a stupid move. But biotech is high risk so those who can't hack it should sell and buy some gilts...

[eggy6198] 03/10/2019 13:53

Thats nice for you whats your position again

[s1zematters] 03/10/2019 13:52

looks like that 120-140p price i mentioned yesterday could arrive sooner than i expected.

[hashertu] 03/10/2019 13:31

hxxps://www.reneuron.com/wp-content/uploads/ReNeuron-corporate-presentation-May-2019.pdf

Page 17 shows the surgical procedure. Seems to me that it is injection directly into the back of eyeball which remains in situ, based on the photographs.
Page 19 gives some individual information on Cohort 5, which I assume were the first 3 patients in Phase IIa.
The untreated (contralateral) eye is shown as being in significantly better condition than the treated eye, in all 3 patients.
I note that the trial has not been stopped due to safety concerns, so I await with interest the explanation, that I am sure will be addressed at the conference next week, about the surgical issues.

[small crow] 03/10/2019 13:18

.."this is just fixed". Agree. in the face of those, generally positive, clinical results this decline (along with sudden appearance of some negative commentators here) doesn't smell right. Could an entity have arranged private transfer of Woodford's stake, then added as many as possible at these low prices (after sowing doubt) and then attempt hostile TO?

[eggy6198] 03/10/2019 13:04

If woodford isnt selling this is just fixed. How low can they take it is the only question before the conference

[dickbush] 03/10/2019 12:58

I also wonder what Woodford is thinking about his holding. Yet another embarrassment: he bought most of his holding in the financing a few years ago. Wasn't that at £5? It will probably be another 3 months before the next update and, if that article is right, new deals may be hard to come by.

[elsa7878] 03/10/2019 12:51

Brokers and large shareholders will know more and will have been asking questions. I would think that the fact that they are clearly not buying says it all...(I have no interest but just making a detached observation).

[napoleon 14th] 03/10/2019 12:38

I remeber XTL - their herpes program went bad when two of the cohort died!
SP went from 40 to 6p.
A year later, deaths were certified to have nowt to do with the treatment.
Volume shot up but share price stayed down due to surplus stock & I bought at c. 6p.
Market ran out of stock the next day. I sold at c.36p two weeks later.
Such are pharmas. IMO there's more + than - in those results.

I paid 80p for my RENE, so plenty of margin.
Will wait for future news before deciding.
Current fall looks like panic &/or manipulation.
Plus we have the inknown in Woodford.